The DoT may soon issue new telecom licences to Idea Cellular which had earlier refused to accept guidelines related to 3G roaming pacts in the unified license, sources said.
The DoT may soon issue new telecom licences to Idea Cellular which had earlier refused to accept guidelines related to 3G roaming pacts in the unified license, sources said. The new licence agreement between DoT and Idea may also incorporate certain clauses proposed by Idea, they added.
The Department had said that it was illegal for telecom operators to sell 3G services in areas where they do not have spectrum. Telecom companies Airtel , Vodafone and Idea Cellular had contested the DoT's point and the matter is now sub-judice.
Telecom tribunal TDSAT had given a split verdict on the dispute between DoT and the three operators over 3G intra-circle roaming pacts. The matter is now pending with the Delhi High Court.
When contacted Idea Cellular refused to comment on the development. Idea had emerged second biggest winner by getting spectrum in 8 circles which included all the seven circles where its licences were cancelled and an additional win in Bihar where it licences were unaffected by the apex court order that cancelled 122 telecom permits in 2G scam.
DoT has also suggested signing Unified Licence agreement for Jammu and Kashmir and Orissa service areas where there is no mention of 3G roaming pact norms.
Idea Cellular stock price
On May 29, 2015, at 09:50 hrs Idea Cellular was quoting at Rs 168.55, down Rs 0.55, or 0.33 percent. The 52-week high of the share was Rs 203.90 and the 52-week low was Rs 129.80.
The company's trailing 12-month (TTM) EPS was at Rs 7.81 per share as per the quarter ended March 2015. The stock's price-to-earnings (P/E) ratio was 21.58. The latest book value of the company is Rs 51.90 per share. At current value, the price-to-book value of the company is 3.25.
READ MORE ON DoT, Idea Cellular, 3G roaming pacts, Airtel, Vodafone , TDSAT, Minister of Communications and IT Kapil Sibal
Set email alert for
ADS BY GOOGLE
video of the day
PSU stocks may give 30-40%; like mid-cap pharma: Dimensions